{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:16:34Z","timestamp":1792030594624,"version":"4.4.0"},"reference-count":118,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["cancertreatmentreviews.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment Reviews"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ctrv.2025.103086","type":"journal-article","created":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T15:08:03Z","timestamp":1767539283000},"page":"103086","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Management of multifocal and metastatic retroperitoneal sarcoma: an updated consensus approach from the transatlantic australasian retroperitoneal sarcoma working group (TARPSWG)"],"prefix":"10.1016","volume":"143","author":[{"given":"Chiara","family":"Fabbroni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward.W.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Sanfilippo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk C.","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Bonvalot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Spalek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winan. J.","family":"Van Houdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel J.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyo Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulazeez","family":"Salawu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol J.","family":"Swallow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susie","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Gyorki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrajit P.","family":"Raut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Mullinax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Albertsmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinando","family":"Cananzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Konieczkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie P.","family":"Grignol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Pennacchioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piergiorgio","family":"Solli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Napolitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena Di","family":"Blasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Stacchiotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri","family":"Tzanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Rutkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toufik","family":"Bouhadiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne M.","family":"Schrage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Sherriff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Callegaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Farma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Fiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai-Kim","family":"Gervais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca A.","family":"Gladdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Nessim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina L.","family":"Roland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee D.","family":"Cranmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa Y.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreyaskumar","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"von Mehren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason K.","family":"Sicklick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Gronchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William W.","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ctrv.2025.103086_b0005","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1097\/SLA.0000000000001447","article-title":"Variability in patterns of recurrence after resection of primary retroperitoneal sarcoma (RPS): a report on 1007 patients from the multi-institutional collaborative RPS working group","volume":"263","author":"Gronchi","year":"2016","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.ctrv.2025.103086_b0010","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1245\/s10434-014-3965-2","article-title":"Management of primary retroperitoneal sarcoma (RPS) in the adult: a consensus approach from the trans-atlantic RPS working group","volume":"22","author":"Trans-Atlantic","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.ctrv.2025.103086_b0015","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1245\/s10434-016-5336-7","article-title":"Management of recurrent retroperitoneal sarcoma (RPS) in the adult: a consensus approach from the trans-atlantic RPS working group","volume":"23","author":"Trans-Atlantic","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.ctrv.2025.103086_b0020","doi-asserted-by":"crossref","first-page":"7873","DOI":"10.1245\/s10434-021-09654-z","article-title":"Management of primary retroperitoneal sarcoma (RPS) in the adult: an updated consensus approach from the transatlantic Australasian RPS working group","volume":"28","author":"Swallow","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.ctrv.2025.103086_b0025","doi-asserted-by":"crossref","first-page":"7335","DOI":"10.1245\/s10434-022-11864-y","article-title":"Management of locally recurrent retroperitoneal sarcoma in the adult: an updated consensus approach from the transatlantic australasian retroperitoneal sarcoma working group","volume":"29","author":"Tseng","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ctrv.2025.103086_b0030","doi-asserted-by":"crossref","unstructured":"Trans-Atlantic Retroperitoneal Sarcoma Working Group . Electronic address, a.m.b.b.c., Management of metastatic retroperitoneal sarcoma: a consensus approach from the Trans-Atlantic Retroperitoneal Sarcoma Working Group (TARPSWG). Ann Oncol, 2018. 29(4): p. 857-871.","DOI":"10.1093\/annonc\/mdy052"},{"issue":"7","key":"10.1016\/j.ctrv.2025.103086_b0035","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1002\/cncr.23774","article-title":"The prognostic impact of dedifferentiation in retroperitoneal liposarcoma: a series of surgically treated patients at a single institution","volume":"113","author":"Mussi","year":"2008","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ctrv.2025.103086_b0040","doi-asserted-by":"crossref","first-page":"70","DOI":"10.32074\/1591-951X-213","article-title":"The 2020 WHO classification of soft tissue tumours: news and perspectives","volume":"113","author":"Sbaraglia","year":"2021","journal-title":"Pathologica"},{"issue":"6","key":"10.1016\/j.ctrv.2025.103086_b0045","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.clinimag.2013.06.009","article-title":"18F-FDG PET\/CT in suspected recurrences of epithelial malignant pleural mesothelioma in asbestos-fibers-exposed patients (comparison to standard diagnostic follow-up)","volume":"37","author":"Niccoli-Asabella","year":"2013","journal-title":"Clin Imaging"},{"issue":"2","key":"10.1016\/j.ctrv.2025.103086_b0050","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ejso.2011.11.001","article-title":"Value of PET scan in patients with retroperitoneal sarcoma treated with preoperative radiotherapy","volume":"38","author":"Alford","year":"2012","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ctrv.2025.103086_b0055","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/7191363","article-title":"Prediction of histologic subtype and FNCLCC grade by SUVmax measured on (18)F-FDG PET\/CT in patients with retroperitoneal liposarcoma","volume":"2021","author":"Li","year":"2021","journal-title":"Contrast Media Mol Imaging"},{"issue":"1","key":"10.1016\/j.ctrv.2025.103086_b0060","doi-asserted-by":"crossref","first-page":"6605","DOI":"10.1038\/s41598-019-43215-5","article-title":"Maximum standardized uptake value on (18)F-fluorodeoxyglucose positron emission tomography\/computed tomography improves outcome prediction in retroperitoneal liposarcoma","volume":"9","author":"Rhu","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.ctrv.2025.103086_b0065","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8363986","article-title":"PET\/CT imaging as a diagnostic tool in distinguishing well-differentiated versus dedifferentiated liposarcoma","volume":"2020","author":"Parkes","year":"2020","journal-title":"Sarcoma"},{"issue":"6","key":"10.1016\/j.ctrv.2025.103086_b0070","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.3390\/curroncol30060398","article-title":"The role of surgery in oligometastatic retroperitoneal sarcoma","volume":"30","author":"Janes","year":"2023","journal-title":"Curr Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2025.103086_b0075","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/SLA.0b013e3181928f2f","article-title":"Multifocality in retroperitoneal sarcoma: a prognostic factor critical to surgical decision-making","volume":"249","author":"Anaya","year":"2009","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.ctrv.2025.103086_b0080","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12893-023-01941-8","article-title":"Development and validation of a nomogram for predicting morbidity in surgically resected primary retroperitoneal sarcoma","volume":"23","author":"Zhuang","year":"2023","journal-title":"BMC Surg"},{"issue":"7","key":"10.1016\/j.ctrv.2025.103086_b0085","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1245\/s10434-014-3643-4","article-title":"Locoregional disease patterns in well-differentiated and dedifferentiated retroperitoneal liposarcoma: implications for the extent of resection?","volume":"21","author":"Tseng","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.ctrv.2025.103086_b0090","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1245\/s10434-014-4130-7","article-title":"Personalizing the approach to retroperitoneal soft tissue sarcoma: histology-specific patterns of failure and postrelapse outcome after primary extended resection","volume":"22","author":"Gronchi","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.ctrv.2025.103086_b0095","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1245\/s10434-020-09445-y","article-title":"Postoperative morbidity after resection of recurrent retroperitoneal sarcoma: a report from the transatlantic Australasian RPS working group (TARPSWG)","volume":"28","author":"Nessim","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.ctrv.2025.103086_b0100","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ejso.2021.10.013","article-title":"Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal sarcomatosis-a systematic review and meta-analysis","volume":"48","author":"Wong","year":"2022","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"10.1016\/j.ctrv.2025.103086_b0105","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1245\/s10434-023-13459-7","article-title":"Significant predictors of postoperative morbidity after radical resection of retroperitoneal sarcoma in a tertiary center","volume":"30","author":"Di Prata","year":"2023","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.ctrv.2025.103086_b0110","doi-asserted-by":"crossref","first-page":"7930","DOI":"10.1245\/s10434-024-16103-0","article-title":"The landmark series: multimodal management of oligometastatic sarcoma","volume":"31","author":"Bonvalot","year":"2024","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ctrv.2025.103086_b0115","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/1357714021000022168","article-title":"The treatment and outcome of patients with soft tissue sarcomas and synchronous metastases","volume":"6","author":"Kane","year":"2002","journal-title":"Sarcoma"},{"issue":"2","key":"10.1016\/j.ctrv.2025.103086_b0120","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/cncr.25418","article-title":"Soft tissue sarcoma presenting with metastatic disease: outcome with primary surgical resection","volume":"117","author":"Ferguson","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.ctrv.2025.103086_b0125","doi-asserted-by":"crossref","unstructured":"F. Tirotta, et al., Liver resection for sarcoma metastases: a systematic review and experience from two European centres, Eur. J. Surg. Oncol. 46(10 Pt A) (2020) 1807\u20131813.","DOI":"10.1016\/j.ejso.2020.05.024"},{"issue":"2","key":"10.1016\/j.ctrv.2025.103086_b0130","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/17453679508995509","article-title":"Size and timing of local recurrence predicts metastasis in soft tissue sarcoma. Growth rate index retrospectively analyzed in 134 patients","volume":"66","author":"Choong","year":"1995","journal-title":"Acta Orthop Scand"},{"issue":"3","key":"10.1016\/j.ctrv.2025.103086_b0135","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1040-8428(97)00017-6","article-title":"Lung metastasectomy: why, when, how","volume":"26","author":"Pastorino","year":"1997","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"10.1016\/j.ctrv.2025.103086_b0140","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.athoracsur.2011.05.052","article-title":"Repeated and aggressive pulmonary resections for leiomyosarcoma metastases extends survival","volume":"92","author":"Burt","year":"2011","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"10.1016\/j.ctrv.2025.103086_b0145","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jamcollsurg.2011.01.007","article-title":"Progression after chemotherapy is a novel predictor of poor outcomes after pulmonary metastasectomy in sarcoma patients","volume":"212","author":"Stephens","year":"2011","journal-title":"J Am Coll Surg"},{"issue":"3","key":"10.1016\/j.ctrv.2025.103086_b0150","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.athoracsur.2008.08.018","article-title":"Management of primary pulmonary artery sarcomas","volume":"87","author":"Blackmon","year":"2009","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"10.1016\/j.ctrv.2025.103086_b0155","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ejso.2008.01.004","article-title":"Factors associated with actual long-term survival following soft tissue sarcoma pulmonary metastasectomy","volume":"35","author":"Smith","year":"2009","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2025.103086_b0160","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jtcvs.2017.02.061","article-title":"Pulmonary metastasectomy with therapeutic intent for soft-tissue sarcoma","volume":"154","author":"Chudgar","year":"2017","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"10.1016\/j.ctrv.2025.103086_b0165","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jtcvs.2014.09.039","article-title":"Risk stratification of patients undergoing pulmonary metastasectomy for soft tissue and bone sarcomas","volume":"149","author":"Lin","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"10.1016\/j.ctrv.2025.103086_b0170","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.thorsurg.2015.09.007","article-title":"Results of pulmonary resection: sarcoma and germ cell tumors","volume":"26","author":"Ceppa","year":"2016","journal-title":"Thorac Surg Clin"},{"issue":"13","key":"10.1016\/j.ctrv.2025.103086_b0175","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.ejca.2014.05.009","article-title":"Pulmonary metastasectomy for soft tissue sarcoma\u2013report from a dual institution experience at the Medical University of Vienna","volume":"50","author":"Schur","year":"2014","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.ctrv.2025.103086_b0180","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/jso.23961","article-title":"Outcomes and clinical predictors of improved survival in a patients undergoing pulmonary metastasectomy for sarcoma","volume":"112","author":"Dossett","year":"2015","journal-title":"J Surg Oncol"},{"issue":"7","key":"10.1016\/j.ctrv.2025.103086_b0185","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1245\/s10434-020-09299-4","article-title":"A new scoring system for predicting the survival of sarcoma patients with pulmonary metastases: sarcoma lung metastasis score","volume":"28","author":"Yamamoto","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2025.103086_b0190","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12957-022-02552-y","article-title":"Survival and prognostic factors in patients undergoing pulmonary metastasectomy for lung metastases from retroperitoneal sarcoma","volume":"20","author":"Takatsu","year":"2022","journal-title":"World J Surg Oncol"},{"issue":"12","key":"10.1016\/j.ctrv.2025.103086_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2024.108619","article-title":"Unraveling the role of local ablative therapies for patients with metastatic soft tissue sarcoma \u2013 a retrospective multicenter study of the Bavarian university hospitals","volume":"50","author":"Burkhard-Meier","year":"2024","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ctrv.2025.103086_b0200","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/jso.25504","article-title":"Long-term results of surgical resection of lung metastases from soft tissue sarcoma: a single center experience","volume":"120","author":"Nevala","year":"2019","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ctrv.2025.103086_b0205","doi-asserted-by":"crossref","unstructured":"Delisle M et al. Metastasectomy in Leiomyosarcoma: A Systematic Review and Pooled Survival Analysis. Cancers (Basel), 2022. 14(13).","DOI":"10.3390\/cancers14133055"},{"issue":"5","key":"10.1016\/j.ctrv.2025.103086_b0210","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/ijc.33264","article-title":"Thoracoscopy vs thoracotomy for the management of metastatic osteosarcoma: a pediatric surgical oncology research collaborative study","volume":"148","author":"Lautz","year":"2021","journal-title":"Int J Can"},{"issue":"5","key":"10.1016\/j.ctrv.2025.103086_b0215","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.clon.2020.01.005","article-title":"Stereotactic body radiotherapy versus metastasectomy in patients with pulmonary metastases from soft tissue sarcoma","volume":"32","author":"Tetta","year":"2020","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ctrv.2025.103086_b0220","doi-asserted-by":"crossref","DOI":"10.1177\/17588359211070646","article-title":"Stereotactic radiotherapy for soft tissue and bone sarcomas: real-world evidence","volume":"14","author":"Spalek","year":"2022","journal-title":"Ther Adv Med Oncol"},{"issue":"4","key":"10.1016\/j.ctrv.2025.103086_b0225","first-page":"265","article-title":"Association between biologically effective dose and local control after stereotactic body radiotherapy for metastatic sarcoma","volume":"8","author":"Somasundaram","year":"2022","journal-title":"J Radiosurg SBRT"},{"key":"10.1016\/j.ctrv.2025.103086_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109824","article-title":"Stereotactic body radiation therapy for sarcoma pulmonary metastases","volume":"187","author":"Lebow","year":"2023","journal-title":"Radiother Oncol"},{"issue":"6","key":"10.1016\/j.ctrv.2025.103086_b0235","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/COC.0000000000001000","article-title":"Stereotactic body radiation therapy for sarcoma pulmonary metastases","volume":"46","author":"Asha","year":"2023","journal-title":"Am J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ctrv.2025.103086_b0240","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.ijrobp.2022.08.028","article-title":"Stereotactic body radiation therapy for lung metastases from sarcoma in oligometastatic patients: a phase 2 study","volume":"114","author":"Navarria","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ctrv.2025.103086_b0245","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/jso.26078","article-title":"Multi-institutional analysis of stereotactic body radiotherapy for sarcoma pulmonary metastases: high rates of local control with favorable toxicity","volume":"122","author":"Baumann","year":"2020","journal-title":"J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2025.103086_b0250","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/jso.24268","article-title":"Efficacy and safety of stereotactic body radiation therapy for the treatment of pulmonary metastases from sarcoma: a potential alternative to resection","volume":"114","author":"Baumann","year":"2016","journal-title":"J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2025.103086_b0255","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s13014-023-02346-w","article-title":"Treatment outcomes of stereotactic body radiation therapy for primary and metastatic sarcoma of the spine","volume":"18","author":"Kim","year":"2023","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.1016\/j.ctrv.2025.103086_b0260","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11060-020-03691-6","article-title":"Local control and patterns of failure for \u201cRadioresistant\u201d spinal metastases following stereotactic body radiotherapy compared to a \u201cRadiosensitive\u201d reference","volume":"152","author":"Zeng","year":"2021","journal-title":"J Neurooncol"},{"issue":"5","key":"10.1016\/j.ctrv.2025.103086_b0265","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.ijrobp.2013.12.042","article-title":"Outcomes and toxicity for hypofractionated and single-fraction image-guided stereotactic radiosurgery for sarcomas metastasizing to the spine","volume":"88","author":"Folkert","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ctrv.2025.103086_b0270","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3171\/2015.11.SPINE151059","article-title":"Stereotactic body radiotherapy for metastatic spinal sarcoma: a detailed patterns-of-failure study","volume":"25","author":"Leeman","year":"2016","journal-title":"J Neurosurg Spine"},{"issue":"1","key":"10.1016\/j.ctrv.2025.103086_b0275","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11060-024-04892-z","article-title":"A systematic review of stereotactic radiosurgery for metastatic spinal sarcomas","volume":"172","author":"Kite","year":"2025","journal-title":"J Neurooncol"},{"issue":"5","key":"10.1016\/j.ctrv.2025.103086_b0280","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/cncr.33306","article-title":"A multi-institutional phase 2 trial of stereotactic body radiotherapy in the treatment of bone metastases in pediatric and young adult patients with sarcoma","volume":"127","author":"Elledge","year":"2021","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ctrv.2025.103086_b0285","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/COC.0000000000000794","article-title":"Multiple Site SBRT in pediatric, adolescent, and young adult patients with recurrent and\/or metastatic sarcoma","volume":"44","author":"Parsai","year":"2021","journal-title":"Am J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ctrv.2025.103086_b0290","doi-asserted-by":"crossref","DOI":"10.1148\/rycan.230011","article-title":"Adaptive radiation therapy: a review of CT-based techniques","volume":"5","author":"Lavrova","year":"2023","journal-title":"Radiol Imaging Cancer"},{"issue":"7","key":"10.1016\/j.ctrv.2025.103086_b0295","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13071523","article-title":"Feasibility and early clinical experience of online adaptive MR-guided radiotherapy of liver tumors","volume":"13","author":"Rogowski","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.ctrv.2025.103086_b0300","article-title":"Hypofractionated radiation therapy for unresectable or metastatic sarcoma lesions","volume":"7","author":"Boyce-Fappiano","year":"2022","journal-title":"Adv Radiat Oncol"},{"issue":"2","key":"10.1016\/j.ctrv.2025.103086_b0305","article-title":"Response to central boost radiation therapy in unresectable retroperitoneal sarcoma: a case series","volume":"10","author":"Burner","year":"2025","journal-title":"Adv Radiat Oncol"},{"issue":"4","key":"10.1016\/j.ctrv.2025.103086_b0310","article-title":"Radiotherapy for the palliation of advanced sarcomas-the effectiveness of radiotherapy in providing symptomatic improvement for advanced sarcomas in a single centre cohort","volume":"7","author":"Tween","year":"2019","journal-title":"Healthcare (Basel)"},{"issue":"3","key":"10.1016\/j.ctrv.2025.103086_b0315","article-title":"Spatially fractionated radiation therapy in sarcomas: a large single-institution experience","volume":"9","author":"Ahmed","year":"2024","journal-title":"Adv Radiat Oncol"},{"issue":"13","key":"10.1016\/j.ctrv.2025.103086_b0320","doi-asserted-by":"crossref","first-page":"4221","DOI":"10.1002\/cam4.3646","article-title":"Proton radiotherapy for recurrent or metastatic sarcoma with palliative quad shot","volume":"10","author":"Lee","year":"2021","journal-title":"Cancer Med"},{"issue":"4","key":"10.1016\/j.ctrv.2025.103086_b0325","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17040624","article-title":"Role of spatially fractionated radiotherapy (LATTICE) treatment in inoperable bulky soft-tissue sarcomas","volume":"17","author":"Majercakova","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.ctrv.2025.103086_b0330","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1667\/RADE-20-00100.1","article-title":"Spatially fractionated radiotherapy (GRID) prior to standard neoadjuvant conventionally fractionated radiotherapy for bulky, high-risk soft tissue and osteosarcomas: feasibility, safety, and promising pathologic response rates","volume":"194","author":"Snider","year":"2020","journal-title":"Radiat Res"},{"issue":"3","key":"10.1016\/j.ctrv.2025.103086_b0335","doi-asserted-by":"crossref","first-page":"494","DOI":"10.2214\/AJR.21.26551","article-title":"Comparison of percutaneous image-guided microwave ablation and cryoablation for sarcoma lung metastases: a 10-year experience","volume":"218","author":"Bourgouin","year":"2022","journal-title":"AJR Am J Roentgenol"},{"issue":"7","key":"10.1016\/j.ctrv.2025.103086_b0340","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00270-020-02471-z","article-title":"CIRSE standards of practice on thermal ablation of liver tumours","volume":"43","author":"Crocetti","year":"2020","journal-title":"Cardiovasc Interv Radiol"},{"issue":"24","key":"10.1016\/j.ctrv.2025.103086_b0345","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15245806","article-title":"The importance of optimal thermal ablation margins in colorectal liver metastases: a systematic review and meta-analysis of 21 studies","volume":"15","author":"Chlorogiannis","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.ctrv.2025.103086_b0350","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00270-020-02432-6","article-title":"CIRSE standards of practice on thermal ablation of primary and secondary lung tumours","volume":"43","author":"Venturini","year":"2020","journal-title":"Cardiovasc Interv Radiol"},{"key":"10.1016\/j.ctrv.2025.103086_b0355","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.713685","article-title":"Stereotactic and robotic minimally invasive thermal ablation of malignant liver tumors: a systematic review and meta-analysis","volume":"11","author":"Tinguely","year":"2021","journal-title":"Front Oncol"},{"issue":"5","key":"10.1016\/j.ctrv.2025.103086_b0360","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.diii.2022.02.004","article-title":"Software-based assessment of tumor margins after percutaneous thermal ablation of liver tumors: a systematic review","volume":"103","author":"Minier","year":"2022","journal-title":"Diagn Interv Imaging"},{"issue":"11","key":"10.1016\/j.ctrv.2025.103086_b0365","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.jvir.2020.05.011","article-title":"Transcatheter CT hepatic arteriography compared with conventional CT fluoroscopy guidance in percutaneous thermal ablation to treat colorectal liver metastases: a single-center comparative analysis of 2 historical cohorts","volume":"31","author":"Puijk","year":"2020","journal-title":"J Vasc Interv Radiol"},{"issue":"1","key":"10.1016\/j.ctrv.2025.103086_b0370","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00280-015-2809-5","article-title":"Clinical practice guidelines for the diagnosis and treatment of patients with soft tissue sarcoma by the Spanish group for research in sarcomas (GEIS)","volume":"77","author":"Garcia del Muro","year":"2016","journal-title":"Cancer Chemother Pharmacol"},{"issue":"4","key":"10.1016\/j.ctrv.2025.103086_b0375","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/CCO.0000000000000377","article-title":"Treatment of retroperitoneal sarcoma: current standards and new developments","volume":"29","author":"van Houdt","year":"2017","journal-title":"Curr Opin Oncol"},{"issue":"4","key":"10.1016\/j.ctrv.2025.103086_b0380","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.soc.2017.05.001","article-title":"Randomized controlled trials in soft tissue sarcoma: we are getting there!","volume":"26","author":"MacNeill","year":"2017","journal-title":"Surg Oncol Clin N Am"},{"issue":"6","key":"10.1016\/j.ctrv.2025.103086_b0385","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13061453","article-title":"Impact of pathological stratification on the clinical outcomes of advanced well-differentiated\/dedifferentiated liposarcoma treated with trabectedin","volume":"13","author":"Fabbroni","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.ctrv.2025.103086_b0390","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14061362","article-title":"Targetable pathways in the treatment of retroperitoneal liposarcoma","volume":"14","author":"Casadei","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.ctrv.2025.103086_b0395","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1097\/SLA.0000000000006345","article-title":"Extracellular vesicle- MDM2 -DNA as a potential liquid biopsy biomarker for disease identification in retroperitoneal liposarcoma","volume":"281","author":"Calore","year":"2025","journal-title":"Ann Surg"},{"issue":"7","key":"10.1016\/j.ctrv.2025.103086_b0400","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.ejso.2016.10.032","article-title":"Primary retroperitoneal soft tissue sarcoma: Imaging appearances, pitfalls and diagnostic algorithm","volume":"43","author":"Messiou","year":"2017","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10.1016\/j.ctrv.2025.103086_b0405","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.soc.2014.07.003","article-title":"Diagnostic imaging of hepatic lesions in adults","volume":"23","author":"Lamba","year":"2014","journal-title":"Surg Oncol Clin N Am"},{"issue":"4","key":"10.1016\/j.ctrv.2025.103086_b0410","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.rpor.2015.12.005","article-title":"Systemic therapy for selected skull base sarcomas: Chondrosarcoma, chordoma, giant cell tumour and solitary fibrous tumour\/hemangiopericytoma","volume":"21","author":"Colia","year":"2016","journal-title":"Rep Pract Oncol Radiother"},{"issue":"6","key":"10.1016\/j.ctrv.2025.103086_b0415","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"issue":"12","key":"10.1016\/j.ctrv.2025.103086_b0420","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1245\/s10434-010-1178-x","article-title":"Peritoneal sarcomatosis: is there a subset of patients who may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy?","volume":"17","author":"Baratti","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ctrv.2025.103086_b0425","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0300594","article-title":"Radical resection and hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of high risk recurrent retroperitoneal sarcoma-a pilot study in a tertiary Asian Centre","volume":"19","author":"Seo","year":"2024","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.ctrv.2025.103086_b0430","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1002\/cncr.20192","article-title":"Hyperthermic intraperitoneal intraoperative chemotherapy after cytoreductive surgery for the treatment of abdominal sarcomatosis: clinical outcome and prognostic factors in 60 consecutive patients","volume":"100","author":"Rossi","year":"2004","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ctrv.2025.103086_b0435","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1001\/jamaoncol.2017.4996","article-title":"Effect of neoadjuvant chemotherapy plus regional hyperthermia on long-term outcomes among patients with localized high-risk soft tissue sarcoma: the EORTC 62961-ESHO 95 randomized clinical trial","volume":"4","author":"Issels","year":"2018","journal-title":"JAMA Oncol"},{"issue":"2","key":"10.1016\/j.ctrv.2025.103086_b0440","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.soc.2011.12.001","article-title":"Pulmonary metastasectomy for soft tissue sarcoma","volume":"21","author":"Smith","year":"2012","journal-title":"Surg Oncol Clin N Am"},{"issue":"9","key":"10.1016\/j.ctrv.2025.103086_b0445","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.3109\/0284186X.2014.899433","article-title":"Response to preoperative chemotherapy in patients undergoing resection of pulmonary metastasis from soft tissue sarcoma - a predictor of outcome?","volume":"53","author":"Ohnstad","year":"2014","journal-title":"Acta Oncol"},{"issue":"4","key":"10.1016\/j.ctrv.2025.103086_b0450","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ejso.2006.01.006","article-title":"Influence of operator experience in radiofrequency ablation of malignant liver tumours on treatment outcome","volume":"32","author":"Hildebrand","year":"2006","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ctrv.2025.103086_b0455","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/01.sla.0000171032.99149.fe","article-title":"Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors","volume":"242","author":"Mulier","year":"2005","journal-title":"Ann Surg"},{"issue":"11","key":"10.1016\/j.ctrv.2025.103086_b0460","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13112769","article-title":"Thermal ablation compared to partial hepatectomy for recurrent colorectal liver metastases: an amsterdam colorectal liver met registry (AmCORE) based study","volume":"13","author":"Dijkstra","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.ctrv.2025.103086_b0465","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s00270-018-1932-1","article-title":"Radiographic local tumor control and pain palliation of sarcoma metastases within the musculoskeletal system with percutaneous thermal ablation","volume":"41","author":"Vaswani","year":"2018","journal-title":"Cardiovasc Interv Radiol"},{"key":"10.1016\/j.ctrv.2025.103086_b0470","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12885-015-1182-4","article-title":"A retrospective chart review of drug treatment patterns and clinical outcomes among patients with metastatic or recurrent soft tissue sarcoma refractory to one or more prior chemotherapy treatments","volume":"15","author":"Wagner","year":"2015","journal-title":"BMC Cancer"},{"issue":"10","key":"10.1016\/j.ctrv.2025.103086_b0475","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1093\/annonc\/mds070","article-title":"Chemotherapy treatment patterns and clinical outcomes in patients with metastatic soft tissue sarcoma. the SArcoma treatment and Burden of Illness in North America and Europe (SABINE) study","volume":"23","author":"Leahy","year":"2012","journal-title":"Ann Oncol"},{"issue":"32","key":"10.1016\/j.ctrv.2025.103086_b0480","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1200\/JCO.2016.67.6684","article-title":"PICASSO III: a phase III, placebo-controlled study of doxorubicin with or without palifosfamide in patients with metastatic soft tissue sarcoma","volume":"34","author":"Ryan","year":"2016","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ctrv.2025.103086_b0485","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1470-2045(14)70063-4","article-title":"Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial","volume":"15","author":"Judson","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctrv.2025.103086_b0490","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/868973","article-title":"Clinical activity and tolerability of a 14-day infusional Ifosfamide schedule in soft-tissue sarcoma","volume":"2013","author":"Martin-Liberal","year":"2013","journal-title":"Sarcoma"},{"issue":"8","key":"10.1016\/j.ctrv.2025.103086_b0495","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1200\/JCO.2015.62.4734","article-title":"Efficacy and safety of trabectedin or dacarbazine for metastatic liposarcoma or leiomyosarcoma after failure of conventional chemotherapy: results of a phase III randomized multicenter clinical trial","volume":"34","author":"Demetri","year":"2016","journal-title":"J Clin Oncol"},{"issue":"19","key":"10.1016\/j.ctrv.2025.103086_b0500","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1200\/JCO.2006.10.4117","article-title":"Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected]","volume":"25","author":"Maki","year":"2007","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ctrv.2025.103086_b0505","doi-asserted-by":"crossref","first-page":"4282","DOI":"10.1002\/cam4.5298","article-title":"Retrospective evaluation of the role of gemcitabine-docetaxel in well-differentiated and dedifferentiated liposarcoma","volume":"12","author":"Thirasastr","year":"2023","journal-title":"Cancer Med"},{"issue":"10028","key":"10.1016\/j.ctrv.2025.103086_b0510","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/S0140-6736(15)01283-0","article-title":"Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial","volume":"387","author":"Schoffski","year":"2016","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ctrv.2025.103086_b0515","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/jamaoncol.2016.0264","article-title":"Progression-free survival among patients with well-differentiated or dedifferentiated liposarcoma treated with CDK4 inhibitor Palbociclib: a phase 2 clinical trial","volume":"2","author":"Dickson","year":"2016","journal-title":"JAMA Oncol"},{"issue":"12","key":"10.1016\/j.ctrv.2025.103086_b0520","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1002\/ijc.33956","article-title":"Real-world use of palbociclib monotherapy in retroperitoneal liposarcomas at a large volume sarcoma center","volume":"150","author":"Nassif","year":"2022","journal-title":"Int J Cancer"},{"issue":"11","key":"10.1016\/j.ctrv.2025.103086_b0525","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1002\/cncr.32795","volume":"126","author":"D'Ambrosio","year":"2020","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.ctrv.2025.103086_b0530","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S1470-2045(22)00380-1","article-title":"Doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin alone as first-line therapy for metastatic or unresectable leiomyosarcoma (LMS-04): a randomised, multicentre, open-label phase 3 trial","volume":"23","author":"Pautier","year":"2022","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.ctrv.2025.103086_b0535","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S1470-2045(17)30622-8","article-title":"Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial","volume":"18","author":"Seddon","year":"2017","journal-title":"Lancet Oncol"},{"issue":"15","key":"10.1016\/j.ctrv.2025.103086_b0540","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1200\/JCO.2001.19.15.3483","article-title":"Phase II clinical investigation of gemcitabine in advanced soft tissue sarcomas and window evaluation of dose rate on gemcitabine triphosphate accumulation","volume":"19","author":"Patel","year":"2001","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.ctrv.2025.103086_b0545","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1634\/theoncologist.2011-0467","volume":"17","author":"Pautier","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.ctrv.2025.103086_b0550","doi-asserted-by":"crossref","unstructured":"van der Graaf WT et al. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet 2012;379(9829):1879-86.","DOI":"10.1016\/S0140-6736(12)60651-5"},{"issue":"18","key":"10.1016\/j.ctrv.2025.103086_b0555","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1200\/JCO.2010.33.6107","article-title":"Randomized phase II study comparing gemcitabine plus dacarbazine versus dacarbazine alone in patients with previously treated soft tissue sarcoma: a Spanish Group for Research on Sarcomas study","volume":"29","author":"Garcia-Del-Muro","year":"2011","journal-title":"J Clin Oncol"},{"issue":"18","key":"10.1016\/j.ctrv.2025.103086_b0560","doi-asserted-by":"crossref","first-page":"5192","DOI":"10.1158\/1078-0432.CCR-13-0776","article-title":"Dacarbazine in solitary fibrous tumor: a case series analysis and preclinical evidence vis-a-vis temozolomide and antiangiogenics","volume":"19","author":"Stacchiotti","year":"2013","journal-title":"Clin Can. Res"},{"issue":"1","key":"10.1016\/j.ctrv.2025.103086_b0565","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S1470-2045(18)30676-4","article-title":"Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trial","volume":"20","author":"Martin-Broto","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ctrv.2025.103086_b0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.113391","article-title":"Regorafenib in advanced solitary fibrous tumour: results from an exploratory phase II clinical study","volume":"195","author":"Stacchiotti","year":"2023","journal-title":"Eur J Can."},{"key":"10.1016\/j.ctrv.2025.103086_b0575","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1186\/s12885-015-1697-8","article-title":"Efficacy of trabectedin in malignant solitary fibrous tumors: a retrospective analysis from the French Sarcoma Group","volume":"15","author":"Khalifa","year":"2015","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.ctrv.2025.103086_b0580","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1177\/1078155218784760","article-title":"Efficacy of bevacizumab and temozolomide therapy in locally advanced, recurrent, and metastatic malignant solitary fibrous tumour: a population-based analysis","volume":"25","author":"de Lemos","year":"2019","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.ctrv.2025.103086_b0585","unstructured":"Moertel CL. SARC006: Phase II trial of chemotherapy in sporadic and neurofibromatosis type 1 (NF1)-associated high-grade malignant peripheral nerve sheath tumors (MPNSTs). in 2013 ASCO Annual Meeting I. 2013."},{"issue":"3","key":"10.1016\/j.ctrv.2025.103086_b0590","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S1470-2045(18)30006-8","article-title":"Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials","volume":"19","author":"D'Angelo","year":"2018","journal-title":"Lancet Oncol"}],"container-title":["Cancer Treatment Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737225002087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305737225002087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T15:56:26Z","timestamp":1770479786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305737225002087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":118,"alternative-id":["S0305737225002087"],"URL":"https:\/\/doi.org\/10.1016\/j.ctrv.2025.103086","relation":{},"ISSN":["0305-7372"],"issn-type":[{"value":"0305-7372","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of multifocal and metastatic retroperitoneal sarcoma: an updated consensus approach from the transatlantic australasian retroperitoneal sarcoma working group (TARPSWG)","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctrv.2025.103086","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103086"}}